We are live on ! Find out more
NMRA icon

Neumora Therapeutics
NMRA

98 hedge funds and large institutions have $41.1M invested in Neumora Therapeutics in 2025 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 28 increasing their positions, 28 reducing their positions, and 40 closing their positions.

New
Increased
Maintained
Reduced
Closed

165% more call options, than puts

Call options by funds: $143K | Put options by funds: $54K

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 28

5.63% less ownership

Funds ownership: 40.27% → 34.64% (-5.6%)

15% less funds holding

Funds holding: 115 → 98 (-17)

37% less capital invested

Capital invested by funds: $65.2M → $41.1M (-$24.1M)

40% less first-time investments, than exits

New positions opened: 24 | Existing positions closed: 40

Holders
98
Holders Change
-17
Holders Change %
-14.78%
% of All Funds
1.29%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
24
Increased
28
Reduced
28
Closed
40
Calls
$143K
Puts
$54K
Net Calls
+$89K
Net Calls Change
-$63K

Top Buyers

Rank Fund Capital Flow
1
Two Sigma Advisers
Two Sigma Advisers
New York
+$798K
2
GCP
GSA Capital Partners
United Kingdom
+$543K
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$491K
4
Millennium Management
Millennium Management
New York
+$389K
5
AC
AlphaCore Capital
California
+$256K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$2.63M
2
UBS Group
UBS Group
Switzerland
-$1.86M
3
State Street
State Street
Massachusetts
-$1.04M
4
Geode Capital Management
Geode Capital Management
Massachusetts
-$803K
5
Bank of America
Bank of America
North Carolina
-$604K
Name Holding Trade Value Shares
Change 		Change in
Stake
VPIM
51
Vanguard Personalized Indexing Management
California
$42.7K +$24.9K +32,922 +130%
YIH
52
Y-Intercept (HK)
Hong Kong
$41.9K +$43.2K +57,072 New
Canada Pension Plan Investment Board
53
Canada Pension Plan Investment Board
Ontario, Canada
$40.8K +$42.2K +55,700 New
Universal-Beteiligungs- und Servicegesellschaft
54
Universal-Beteiligungs- und Servicegesellschaft
Germany
$40.8K +$42.2K +55,659 New
HF
55
HRT Financial
New York
$33K +$34.1K +45,064 New
ANTB
56
AMG National Trust Bank
Colorado
$31.8K – – –
CFM
57
Catalyst Funds Management
Australia
$28.9K +$29.8K +39,400 New
Carson Wealth (CWM LLC)
58
Carson Wealth (CWM LLC)
Nebraska
$26K +$7.98K +10,537 +42%
SB
59
SIG Brokerage
New York
$26K – – –
Wealth Enhancement Advisory Services
60
Wealth Enhancement Advisory Services
Minnesota
$24.5K +$10.5K +13,862 +87%
CUAMC
61
China Universal Asset Management Company
China
$23.8K +$61 +80 +0.2%
RS
62
R Squared
Hong Kong
$18.4K +$19K +25,063 New
TRCT
63
Tower Research Capital (TRC)
New York
$17K +$2.51K +3,316 +17%
Hudson Bay Capital Management
64
Hudson Bay Capital Management
Connecticut
$16.5K +$17K +22,449 New
EGM
65
Engineers Gate Manager
New York
$15.8K -$4.22K -5,571 -20%
Bank of New York Mellon
66
Bank of New York Mellon
New York
$14.5K -$158K -208,019 -91%
Citigroup
67
Citigroup
New York
$14K -$35.4K -46,721 -71%
Citadel Advisors
68
Citadel Advisors
Florida
$12.6K +$13K +17,187 New
CGL
69
Clarius Group LLC
Washington
$12.5K – – –
HSA
70
HBK Sorce Advisory
Pennsylvania
$11.9K +$12.3K +16,232 New
JF
71
Jump Financial
Illinois
$11.5K -$7.01K -9,256 -37%
WP
72
Woodline Partners
California
$11K – – –
Squarepoint
73
Squarepoint
New York
$10.9K -$85.7K -113,176 -88%
GSC
74
Ground Swell Capital
South Carolina
$9.38K +$9.69K +12,790 New
Barclays
75
Barclays
United Kingdom
$9.32K -$71.2K -94,025 -88%
1 2
3
4 5

NMRA Hedge Fund Activity: Q2 2025 in Review

98 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Neumora Therapeutics (NMRA) for Q2 2025, worth a combined $41.1M — down 37% from $65.2M a quarter earlier.

Sellers outnumbered buyers: 40 funds closed out of NMRA and 24 opened new positions — a net loss of 16 holders — while 28 trimmed existing stakes and 28 added.

The largest buyer was Two Sigma Advisers, adding an estimated $798K. The largest seller was BlackRock, cutting an estimated $2.63M.

  • 98 institutional investors held Neumora Therapeutics (NMRA) as of Q2 2025, down from 115 in Q1 2025.
  • Funds reported $41.1M of Neumora Therapeutics stock for Q2 2025, down 37% quarter-over-quarter.
  • 24 funds opened new Neumora Therapeutics positions in Q2 2025 and 40 closed out, a net change of -16 holders.
  • The largest Neumora Therapeutics buyer in Q2 2025 was Two Sigma Advisers, an estimated $798K added.
  • The largest Neumora Therapeutics seller in Q2 2025 was BlackRock, an estimated $2.63M sold.

Based on aggregated 13F filings for Q2 2025.